Sodium‐glucose co‐transporter‐2 inhibitors and the risk of venous thromboembolism: A nationwide population‐based study and meta‐analysis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sodium‐glucose co‐transporter‐2 inhibitors and the risk of venous thromboembolism: A nationwide population‐based study and meta‐analysis
Authors
Keywords
-
Journal
DIABETES-METABOLISM RESEARCH AND REVIEWS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-20
DOI
10.1002/dmrr.3739
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sodium‐glucose cotransporter 2 inhibitors and the risk of venous thromboembolism: A population‐based cohort study
- (2023) Stephanie Aloe et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Incidence and risk factors of venous thromboembolism in men and women
- (2022) Marcus M. Lind et al. THROMBOSIS RESEARCH
- Glucagon‐like peptide‐1 receptor agonists improve biomarkers of inflammation and oxidative stress: A systematic review and meta‐analysis of randomised controlled trials
- (2021) Jonathan J. H. Bray et al. DIABETES OBESITY & METABOLISM
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists
- (2021) Agata Winiarska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pulmonary embolism and deep vein thrombosis: Similar but different
- (2021) Nicolas Wenger et al. THROMBOSIS RESEARCH
- Association of Sodium-Glucose Cotransporter–2 Inhibitors With Fracture Risk in Older Adults With Type 2 Diabetes
- (2021) Min Zhuo et al. JAMA Network Open
- Sodium-Glucose Co-Transporter 2 Inhibitors and the Risk of Venous Thromboembolism in Patients with Type 2 Diabetes: A Cohort Study
- (2020) Niklas Schmedt et al. AMERICAN JOURNAL OF MEDICINE
- Using the E-Value to Assess the Potential Effect of Unmeasured Confounding in Observational Studies
- (2019) Sebastien Haneuse et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sodium glucose cotransporter (SGLT)-2 inhibitors: do we need them for glucose-lowering, for cardiorenal protection or both?
- (2019) Rosalie A. Scholtes et al. DIABETES OBESITY & METABOLISM
- A review of the mechanism of action, metabolic profile and haemodynamic effects of sodium‐glucose co‐transporter‐2 inhibitors
- (2019) Emily Brown et al. DIABETES OBESITY & METABOLISM
- Effects of sodium‐glucose cotransporter 2 inhibitors on risk of venous thromboembolism in patients with type 2 diabetes: A systematic review and meta‐analysis
- (2019) Aihua Wang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Taiwan’s National Health Insurance Research Database: past and future
- (2019) Cheng-Yang Hsieh et al. Clinical Epidemiology
- WITHDRAWN: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2019) Pouya Saeedi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners
- (2019) Rishi J Desai et al. BMJ-British Medical Journal
- Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: the potential contribution to diabetes complications and cardiovascular disease
- (2018) Fabrice Bonnet et al. DIABETES & METABOLISM
- Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study
- (2018) Peter Ueda et al. BMJ-British Medical Journal
- Pharmacological aspects of the safety of gliflozins
- (2017) Jean-Luc Faillie PHARMACOLOGICAL RESEARCH
- Efficacy and Safety of Canagliflozin in Individuals Aged 75 and Older with Type 2 Diabetes Mellitus: A Pooled Analysis
- (2016) Alan J. Sinclair et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Risks of venous thromboembolism in patients with liver cirrhosis: a nationwide cohort study in Taiwan
- (2015) K.-J. Ng et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Nationwide Population Science
- (2015) Ann W. Hsing et al. JAMA Internal Medicine
- Is Venous Thromboembolism a Chronic Inflammatory Disease?
- (2014) G. Piazza et al. CLINICAL CHEMISTRY
- Venous Thromboembolism in Patients with Diabetes Mellitus
- (2012) Gregory Piazza et al. AMERICAN JOURNAL OF MEDICINE
- Hematocrit and the Risk of Recurrent Venous Thrombosis: A Prospective Cohort Study
- (2012) Lisbeth Eischer et al. PLoS One
- How to Deal with Measures of Association: A Short Guide for the Clinician
- (2011) M.J. Knol et al. CEREBROVASCULAR DISEASES
- The Hazards of Hazard Ratios
- (2009) Miguel A. Hernán EPIDEMIOLOGY
- Hematocrit and risk of venous thromboembolism in a general population. The Tromso study
- (2009) S. K. Braekkan et al. HAEMATOLOGICA
- Common problems related to the use of number needed to treat
- (2009) Andreas Stang et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
- (2009) Peter C. Austin STATISTICS IN MEDICINE
- Cardiovascular Risk Factors and Venous Thromboembolism
- (2007) Walter Ageno et al. CIRCULATION
- Chronic Kidney Disease Increases Risk for Venous Thromboembolism
- (2007) K. Wattanakit et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now